On August 13, Astera Labs, Inc. rose 3.11% in regular trading, trading at $329.045/share, with turnover of $215 million.
On the news front, the semiconductor sector continued its strong recovery momentum, with Micron Technology up 3.65%, Intel up 4.89%, AMD up 2.60%, and NVIDIA up 0.84%, reflecting a systematic industry rebound. Astera Labs previously reported Q2 results that significantly exceeded expectations, with adjusted EPS of $0.80 versus the $0.69 estimate, and revenue of $392.4 million beating the $360.7 million consensus. The company's Q3 guidance of $540-560 million far surpassed the market expectation of $417 million. RBC Capital raised its price target to $500 from $425, maintaining an Outperform rating, while Morgan Stanley lifted its target to $335 from $240, maintaining Overweight. The current advance continues the oversold recovery rhythm driven by sector-wide strength and robust fundamental support.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments